Evidence map›Paper›PMID 26130933›Full record

ReviewPharmacognosy research

Review of clinical studies of Polygonum multiflorum Thunb. and its isolated bioactive compounds.

Guy-Armel Bounda, Y U Feng

Registry-linked trialAbstract readReview
In one paragraph

Review in Pharmacognosy research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04249869 (The Effect of Traditional Chinese Medicine), which is not on this map. Cited by 38 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04249869 phase1 / phase2unknown statusnot on this map

The Effect of Traditional Chinese Medicine (VGH-AD1) on Patients With Alzheimer's Disease: A Double-blinded Randomized Placebo-controlled Cross-over Study

TypeinterventionalSponsorTaipei Veterans General Hospital, TaiwanRan2020 to 2020Enrolled28ConditionsAlzheimer DiseaseArmsVGH-AD1
3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Bioinspired engineering ofFrontiers in physiology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Efficacy of Heshouwu () on gut mircobiota in mice with autoimmune encephalomyelitis.Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 2023
    Article
  10. Article
  11. Assessing potential liver injury induced byPharmaceutical biology · 2022
    Article
  12. Exploratory Quality Control Study forMolecules (Basel, Switzerland) · 2022
    Article
  13. A review of alpha-glucosidase inhibitors from plants as potential candidates for the treatment of type-2 diabetes.Phytochemistry reviews : proceedings of the Phytochemical Society of Europe · 2022
    Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Plants (Basel, Switzerland) · 2021
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Guy-Armel BoundaDepartment of Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu 210009, China.
Y U FengDepartment of Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu 210009, China ; Key Laboratory of Drug Quality Control and Pharmacovigilance, China Pharmaceutical University, Ministry of Education, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polygonum multiflorum Thunb. (PMT), officially listed in the Chinese Pharmacopoeia, is one of the most popular perennial Chinese traditional medicines known as He shou wu in China and East Asia, and as Fo-ti in North America. Mounting pharmacological studies have stressed out its key benefice for the treatment of various diseases and medical conditions such as liver injury, cancer, diabetes, alopecia, atherosclerosis, and neurodegenerative diseases as well. International databases such as PubMed/Medline, Science citation Index and Google Scholar were searched for clinical studies recently published on P. multiflorum. Various clinical studies published articles were retrieved, providing information relevant to pharmacokinetics-pharmacodynamics analysis, sleep disorders, dyslipidemia treatment, and neurodegenerative diseases. This review is an effort to update the clinical picture of investigations ever carried on PMT and/or its isolated bio-compounds and to enlighten its therapeutic assessment.

Indexed as

Clinical pharmacokineticsclinical studiesherbal hepatotoxicityPolygonum multiflorum Thunb.therapeutic assessment

Identifiers

PMID26130933
PMCPMC4471648

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.